Stay updated on Durvalumab Safety Post Chemo Radiation in Stage III NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab Safety Post Chemo Radiation in Stage III NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab Safety Post Chemo Radiation in Stage III NSCLC Clinical Trial page

  1. Check
    11 days ago
    No Change Detected
  2. Check
    18 days ago
    No Change Detected
  3. Check
    25 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Footer revision label updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-21T19:49:43.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 in the page history.
    Difference
    0.1%
    Check dated 2026-03-07T04:43:47.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    A new revision v3.4.2 was added to the history, replacing the previous v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-13T13:41:29.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1 in the page history; no visible changes to study details or content.
    Difference
    0.1%
    Check dated 2026-02-06T09:10:06.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4 and removed Revision: v3.3.3 from the page's revision history.
    Difference
    0.1%
    Check dated 2026-01-15T04:47:08.000Z thumbnail image
  9. Check
    120 days ago
    Change Detected
    Summary
    Revision: v3.3.3 has been added to the history, and HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed from the page footer. These updates reflect minor metadata changes to the page's revision history.
    Difference
    0.1%
    Check dated 2025-12-24T14:54:57.000Z thumbnail image

Stay in the know with updates to Durvalumab Safety Post Chemo Radiation in Stage III NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab Safety Post Chemo Radiation in Stage III NSCLC Clinical Trial page.